Post-approval studies (Phase 4)Study completedNCT03927391
What this trial is testing
Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side Effects
Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Radboud University Medical Center 57